Drugs / LASW1835
last change Nov 2015 re-read 2 minutes ago

LASW1835

Developed for
psoriasis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01726933 Comparator Nov 2012 → Oct 2014 psoriasis Almirall, S.A. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LASW1835 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01726933